Heron Financial Group, LLC Moderna, Inc. Transaction History

Heron Financial Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	BUY	$135.66 - $197.02 $29,845 - $43,344	220 Added 16.82%	1,528 $234,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $154,841 - $274,732	1,308 New	1,308 $234,000
Q2 2022 Jul 29, 2022	BUY	$117.13 - $176.59 $11,478 - $17,305	98 Added 7.04%	1,490 $213,000
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $176,032 - $327,189	1,392 New	1,392 $240,000
Q4 2021 Feb 04, 2022	SELL	$225.82 - $368.51 $173,203 - $282,647	-767 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$221.9 - $484.47 $170,197 - $371,588	767 New	767 $295,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Heron Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Heron Financial Group, LLC with notifications on news.